Home LiteratureArticle Details
PMID: 17591978 Published · ppublish English Comparative Study Journal Article Research Support, Non-U.S. Gov't

Radiogenic lymphangiogenesis in the skin.

The American journal of pathology ·Vol. 171 ·No. 1 ·2007-07-00 ·Pages 338-48

Jackowski S, Janusch M, Fiedler E, Marsch WC, Ulbrich EJ, Gaisbauer G, Dunst J, Kerjaschki D, Helmbold P

Abstract

The time course of microvascular changes in the environment of irradiated tumors was studied in a standardized human protocol. Eighty skin biopsies from 40 patients with previously treated primary breast cancer were taken from irradiated skin and corresponding contralateral unirradiated control areas 2 to 8 weeks, 11 to 14 months, or 17+ months after radiotherapy (skin equivalent dose 30 to 40 Gy). Twenty-two biopsies of 11 melanoma patients who had undergone lymph node dissection were used for unirradiated control. We found an increase of total podoplanin(+) lymphatic microvessel density resulting mainly from a duplication of the density of smallest lymphatic vessels (diameter <10 microm) in the samples taken 1 year after radiation. Our findings implicate radiogenic lymphangiogenesis during the 1st year after therapy. The numbers of CD68(+) and vascular endothelial growth factor-C(+) cells were highly elevated in irradiated skin in the samples taken 2 to 8 weeks after radiotherapy. Thus, our results indicate that vascular endothelial growth factor-C expression by invading macrophages could be a pathogenetic route of induction of radiogenic lymphangiogenesis.

MeSH Terms
Adult Aged Antigens, CD/metabolism Antigens, Differentiation, Myelomonocytic/metabolism Breast Neoplasms/radiotherapy,surgery Female Humans Lymphangiogenesis/radiation effects Lymphatic Vessels/radiation effects Male Melanoma/blood supply,pathology Middle Aged Neovascularization, Pathologic Radiotherapy/adverse effects Skin/radiation effects Skin Neoplasms/blood supply,pathology Vascular Endothelial Growth Factor C/metabolism Vascular Endothelial Growth Factor D/metabolism
Chemicals
Antigens, CD Antigens, Differentiation, Myelomonocytic CD68 antigen, human Vascular Endothelial Growth Factor C Vascular Endothelial Growth Factor D
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
Jackowski Susanne
Department of Dermatology, University of Heidelberg, Heidelberg, Germany.
Janusch Matthias
Fiedler Eckhard
Marsch Wolfgang C
Ulbrich Eva J
Gaisbauer Gabriele
Dunst Jürgen
Kerjaschki Dontscho
Helmbold Peter
References (47)
47 references, click to expand
  1. Peripheral blood platelets express VEGF-C and VEGF which are released during platelet activation.
    Thromb Haemost. 1998 Jul;80(1):171-5 PMID: 9684805
  2. Up-regulation of vascular endothelial growth factor C in breast cancer cells by heregulin-beta 1. A critical role of p38/nuclear factor-kappa B signaling pathway.
    J Biol Chem. 2003 Feb 21;278(8):5750-9 PMID: 12471041
  3. Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium.
    Am J Pathol. 1999 Feb;154(2):385-94 PMID: 10027397
  4. Complete and specific inhibition of adult lymphatic regeneration by a novel VEGFR-3 neutralizing antibody.
    J Natl Cancer Inst. 2005 Jan 5;97(1):14-21 PMID: 15632376
  5. Vascular endothelial growth factor D is dispensable for development of the lymphatic system.
    Mol Cell Biol. 2005 Mar;25(6):2441-9 PMID: 15743836
  6. The tumor bed effect: increased metastatic dissemination from hypoxia-induced up-regulation of metastasis-promoting gene products.
    Cancer Res. 2005 Mar 15;65(6):2387-96 PMID: 15781654
  7. The pathology of ionizing radiation as defined by morphologic patterns.
    Acta Oncol. 2005;44(1):13-22 PMID: 15848902
  8. Recent progress in defining mechanisms and potential targets for prevention of normal tissue injury after radiation therapy.
    Int J Radiat Oncol Biol Phys. 2005 May 1;62(1):255-9 PMID: 15850930
  9. Vascular endothelial growth factor-C expression and invasive phenotype in ovarian carcinomas.
    Clin Cancer Res. 2005 May 1;11(9):3225-32 PMID: 15867217
  10. Expression of a CD44 variant and VEGF-C and the implications for lymphatic metastasis and long-term prognosis of human breast cancer.
    J Exp Clin Cancer Res. 2005 Mar;24(1):75-82 PMID: 15943035
  11. Overexpression of VEGF-C causes transient lymphatic hyperplasia but not increased lymphangiogenesis in regenerating skin.
    Circ Res. 2005 Jun 10;96(11):1193-9 PMID: 15890974
  12. Endostatin inhibits lymph node metastasis by a down-regulation of the vascular endothelial growth factor C expression in tumor cells.
    Clin Exp Metastasis. 2005;22(1):31-8 PMID: 16132576
  13. The crucial role of macrophages in lymphangiogenesis.
    J Clin Invest. 2005 Sep;115(9):2316-9 PMID: 16138185
  14. Vascular damage after fractionated whole-brain irradiation in rats.
    Radiat Res. 2005 Nov;164(5):662-8 PMID: 16238444
  15. Breast cancer-related lymphedema.
    Mayo Clin Proc. 2005 Nov;80(11):1480-4 PMID: 16295027
  16. Staging system for breast cancer: revisions for the 6th edition of the AJCC Cancer Staging Manual.
    Surg Clin North Am. 2003 Aug;83(4):803-19 PMID: 12875597
  17. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins.
    Nat Immunol. 2004 Jan;5(1):74-80 PMID: 14634646
  18. Early radiation-induced endothelial cell loss and blood-spinal cord barrier breakdown in the rat spinal cord.
    Radiat Res. 2004 Feb;161(2):143-52 PMID: 14731076
  19. VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment.
    J Clin Invest. 2004 Apr;113(7):1040-50 PMID: 15057311
  20. The influence of radiation on blood vessels and circulation. Chapter IV. Structural changes in blood vessels.
    Curr Top Radiat Res Q. 1974 Jun;10(1):58-74 PMID: 4601559
  21. Ultrastructure of the human dermal microcirculation. IV. Valve-containing collecting veins at the dermal-subcutaneous junction.
    J Invest Dermatol. 1983 Nov;81(5):438-42 PMID: 6631054
  22. Response of swine skin microvasculature to acute single exposures of X rays: quantification of endothelial changes.
    Radiat Res. 1984 Apr;98(1):37-51 PMID: 6718694
  23. Correlation of the dermal microvasculature morphology with the epidermal and the endothelial population changes produced by single X ray fractions of 1649, 2231 and 2619 rad in swine.
    Int J Radiat Oncol Biol Phys. 1985 Sep;11(9):1639-46 PMID: 4030432
  24. Long-term changes in the haversian systems following high-dose irradiation. An ultrastructural and quantitative histomorphological study.
    J Bone Joint Surg Am. 1994 May;76(5):722-38 PMID: 8175821
  25. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development.
    Proc Natl Acad Sci U S A. 1995 Apr 11;92(8):3566-70 PMID: 7724599
  26. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases.
    EMBO J. 1996 Jan 15;15(2):290-98 PMID: 8617204
  27. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice.
    Science. 1997 May 30;276(5317):1423-5 PMID: 9162011
  28. Podoplanin, novel 43-kd membrane protein of glomerular epithelial cells, is down-regulated in puromycin nephrosis.
    Am J Pathol. 1997 Oct;151(4):1141-52 PMID: 9327748
  29. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4).
    Proc Natl Acad Sci U S A. 1998 Jan 20;95(2):548-53 PMID: 9435229
  30. Expression of vascular endothelial growth factors A, B, C, and D and their relationships to lymph node status in lung adenocarcinoma.
    Clin Cancer Res. 2000 Jun;6(6):2431-9 PMID: 10873096
  31. VEGF: an update on biological and therapeutic aspects.
    Curr Opin Biotechnol. 2000 Dec;11(6):617-24 PMID: 11102799
  32. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis.
    Nat Med. 2001 Feb;7(2):192-8 PMID: 11175850
  33. Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice.
    EMBO J. 2001 Mar 15;20(6):1223-31 PMID: 11250889
  34. Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth.
    Cancer Res. 2001 Mar 1;61(5):1786-90 PMID: 11280723
  35. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma.
    J Clin Oncol. 2001 Aug 15;19(16):3635-48 PMID: 11504745
  36. Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma.
    Am J Pathol. 2001 Sep;159(3):893-903 PMID: 11549582
  37. Lymphatic vessels as targets of tumor therapy?
    J Exp Med. 2001 Sep 17;194(6):F37-42 PMID: 11561002
  38. Vascular growth factors and lymphangiogenesis.
    Physiol Rev. 2002 Jul;82(3):673-700 PMID: 12087132
  39. Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis.
    Am J Pathol. 2002 Sep;161(3):947-56 PMID: 12213723
  40. Prox1 is a master control gene in the program specifying lymphatic endothelial cell fate.
    Dev Dyn. 2002 Nov;225(3):351-7 PMID: 12412020
  41. Identification of vascular lineage-specific genes by transcriptional profiling of isolated blood vascular and lymphatic endothelial cells.
    Am J Pathol. 2003 Feb;162(2):575-86 PMID: 12547715
  42. Lymphatic endothelial progenitor cells contribute to de novo lymphangiogenesis in human renal transplants.
    Nat Med. 2006 Feb;12(2):230-4 PMID: 16415878
  43. The sialomucin CD34 is a marker of lymphatic endothelial cells in human tumors.
    Am J Pathol. 2006 Mar;168(3):1045-53 PMID: 16507917
  44. Podoplanin: a novel diagnostic immunohistochemical marker.
    Adv Anat Pathol. 2006 Mar;13(2):83-8 PMID: 16670463
  45. Ionizing radiation inhibits tumor neovascularization by inducing ineffective angiogenesis.
    Cancer Biol Ther. 2005 Dec;4(12):1395-1400 PMID: 16676437
  46. Lymphangiogenic growth factor responsiveness is modulated by postnatal lymphatic vessel maturation.
    Am J Pathol. 2006 Aug;169(2):708-18 PMID: 16877368
  47. International Consensus Panel on the treatment of primary breast cancer. V: Update 1998.
    Recent Results Cancer Res. 1998;152:481-97 PMID: 9928582
Article Info
Journal
The American journal of pathology
Abbr.
Am J Pathol
ISSN
0002-9440
Published
2007-07-00
Pages
338-48
Language
English
Region
United States
NLM ID
0370502
PMCID
PMC1941592
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com